SVA [SINOVAC BIOTECH] 6-K: Sinovac Files 2016 Annual Report on Form 20-F

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-22
Original SEC Filing: Click here


Webplus: SVA/20171122/6-K/2_EX-99.1/000.htm SEC Original: tv480143_ex99-1.htm
Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results Fourth Quarter 2016 Financial highlights Ÿ Quarterly sales from continuing operations were $31.4 million compared to $23.0 million in the prior year period, an increase of 36.7%. Sales increased primarily due to revenue generated by the Company’s EV71 vaccine. Ÿ Net income attributable to




Webplus: SVA/20171122/6-K/1/000.htm SEC Original: tv480143_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-22CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085

Home Page Forums

By | 2017-11-23T03:15:02+00:00 November 22nd, 2017|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar